Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Samis

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Blood Advances|July 26, 2021
A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safetyNobuko Hijiya, Alexey Maschan, Carmelo Rizzari, et al.
Blood Advances|September 22, 2023
The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG studyNobuko Hijiya, Alexey Maschan, Carmelo Rizzari, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Blood Advances|July 26, 2021
A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safetyNobuko Hijiya, Alexey Maschan, Carmelo Rizzari, et al.
Blood Advances|September 22, 2023
The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG studyNobuko Hijiya, Alexey Maschan, Carmelo Rizzari, et al.
Pageof 2